Literature DB >> 1793076

Airway eosinophilia and airway hyperreactivity are parallel rather than sequential events in the guinea-pig.

I D Chapman1, K Boubekeur, J Morley.   

Abstract

It is known that eosinophil activation in the airways is associated with epithelial damage in both guinea-pigs and man and it has been presumed that airway hyperreactivity arises in consequence of these events. However, infusion of (+/- )isoprenaline induces airway hyperreactivity in the guinea-pig despite a reduction of eosinophil numbers in the airway lumen, whilst rh-GM-CSF or rh-IL3 induce eosinophilia of the airways without attendant airway hyperreactivity. These findings complement earlier studies which showed that airway hyperreactivity in sensitized animals reacting to inhaled allergen could not be correlated with the number of eosinophils in the airway lumen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793076

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN: 0379-0363


  4 in total

1.  Ozone differentially modulates airway responsiveness in atopic versus nonatopic guinea pigs.

Authors:  Richard B Schlesinger; Mitchell D Cohen; Terry Gordon; Christine Nadziejko; Judith T Zelikoff; Maureen Sisco; Jean F Regal; Margaret G Ménache
Journal:  Inhal Toxicol       Date:  2002-05       Impact factor: 2.724

2.  Kinetics of eosinophilia and eosinophil activation in the development of non-allergic bronchial hyperresponsiveness in guinea pigs injected with Sephadex beads.

Authors:  K Maghni; M J Simard; D Arseneault; P Sirois
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

3.  Relationship between the development of bronchial hyperresponsiveness and the airway eosinophilia in guinea pigs following injection with Sephadex beads.

Authors:  K Maghni; M J Simard; S Cloutier; D Arseneault; P Sirois
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

4.  The effect of platelet-activating factor on the responsiveness of the human nasal airway.

Authors:  C E Austin; J C Foreman
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.